Journal article · 2020
Design, synthesis and biological evaluation of erythrina derivatives bearing a 1,2,3-triazole moiety as PARP-1 inhibitors
Bioorganic Chemistry, 96, 103575 · Published 10 January 2020 · DOI 10.1016/j.bioorg.2020.103575
In brief
“Design, synthesis and biological evaluation of erythrina derivatives bearing a 1,2,3-triazole moiety as PARP-1 inhibitors” is a 2020 journal article by Shuai Li and 6 co-authors, published in Bioorganic Chemistry. OpenAlex counts 41 citations as of 19 November 2026, which puts it in the top 6% of works published in 2020 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 41
- Most cited in
- 2025 (9)
- Field-weighted impact
- 2.20
- References
- 45
- Authors
- 7
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Li, S., Li, X., Zhang, T., Zhu, J., Xue, W.-H., Qian, X.-H., & Meng, F. (2020). Design, synthesis and biological evaluation of erythrina derivatives bearing a 1,2,3-triazole moiety as PARP-1 inhibitors. Bioorganic Chemistry, 96, 103575. https://doi.org/10.1016/j.bioorg.2020.103575
MLA 9
Li, Shuai, et al. “Design, synthesis and biological evaluation of erythrina derivatives bearing a 1,2,3-triazole moiety as PARP-1 inhibitors.” Bioorganic Chemistry, vol. 96, 2020, p. 103575. https://doi.org/10.1016/j.bioorg.2020.103575.
Chicago
Li, Shuai, Xinyang Li, Tingjian Zhang, Jü Zhu, Wen-han Xue, Xin-hua Qian, and Fan‐hao Meng. 2020. “Design, synthesis and biological evaluation of erythrina derivatives bearing a 1,2,3-triazole moiety as PARP-1 inhibitors.” Bioorganic Chemistry 96: 103575. https://doi.org/10.1016/j.bioorg.2020.103575.
Harvard
Li, S. et al. (2020) ‘Design, synthesis and biological evaluation of erythrina derivatives bearing a 1,2,3-triazole moiety as PARP-1 inhibitors’, Bioorganic Chemistry, 96, p. 103575. doi:10.1016/j.bioorg.2020.103575.
IEEE
S. Li et al., “Design, synthesis and biological evaluation of erythrina derivatives bearing a 1,2,3-triazole moiety as PARP-1 inhibitors,” Bioorganic Chemistry, vol. 96, p. 103575, 2020, doi: 10.1016/j.bioorg.2020.103575.
BibTeX
@article{li2020design,
title = {{Design, synthesis and biological evaluation of erythrina derivatives bearing a 1,2,3-triazole moiety as PARP-1 inhibitors}},
author = {Li, Shuai and Li, Xinyang and Zhang, Tingjian and Zhu, Jü and Xue, Wen-han and Qian, Xin-hua and Meng, Fan‐hao},
journal = {Bioorganic Chemistry},
year = {2020},
volume = {96},
pages = {103575},
doi = {10.1016/j.bioorg.2020.103575},
url = {https://doi.org/10.1016/j.bioorg.2020.103575}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2020 | 4 | |
| 2021 | 5 | |
| 2022 | 8 | |
| 2023 | 7 | |
| 2024 | 3 | |
| 2025 | 9 | |
| 2026 | 5 |
Its field-weighted citation impact is 2.20: it has been cited 2.20 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- 1,2,3-triazoles
- PARP-1 inhibitors
- poly(ADP-ribose) polymerase
- rucaparib
- A549 cells
- lung cancer
- apoptosis
- mitochondrial pathway
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Li, S., Li, X., Zhang, T., Zhu, J., Xue, W.-H., Qian, X.-H., & Meng, F. (2020). Design, synthesis and biological evaluation of erythrina derivatives bearing a 1,2,3-triazole moiety as PARP-1 inhibitors. Bioorganic Chemistry, 96, 103575. https://doi.org/10.1016/j.bioorg.2020.103575
How many times has this paper been cited?
41 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Shuai Li, Xinyang Li, Tingjian Zhang, Jü Zhu, Wen-han Xue, Xin-hua Qian, Fan‐hao Meng.
What is the DOI of this paper?
10.1016/j.bioorg.2020.103575, permanently at https://doi.org/10.1016/j.bioorg.2020.103575. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.